Gérard Michel London

Gérard Michel London's AcademicInfluence.com Rankings

Philosophy

#4499

World Rank

#7035

Historical Rank

Logic

#1933

World Rank

#2806

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Gérard Michel London Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gérard Michel London's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Impact of aortic stiffness on survival in end-stage renal disease. (1999) (2181)
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. (2003) (1745)
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’ (2010) (1588)
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. (1999) (1549)
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease (2001) (1181)
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure (2001) (1021)
Arterial stiffening and vascular calcifications in end-stage renal disease. (2000) (984)
Arterial Wave Reflections and Survival in End-Stage Renal Failure (2001) (889)
Central Pulse Pressure and Mortality in End-Stage Renal Disease (2002) (831)
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. (2012) (795)
Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. (1998) (607)
Arterial calcifications and bone histomorphometry in end-stage renal disease. (2004) (569)
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. (2005) (541)
Aortic pulse wave velocity index and mortality in end-stage renal disease. (2003) (528)
Cardiac and arterial interactions in end-stage renal disease. (1996) (497)
Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol (2001) (467)
Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. (2001) (466)
Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. (2007) (434)
Stiffness of Capacitive and Conduit Arteries: Prognostic Significance for End-Stage Renal Disease Patients (2005) (399)
Aortic and large artery compliance in end-stage renal failure. (1990) (398)
Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease (2002) (385)
Atherosclerosis and arteriosclerosis in chronic renal failure. (1997) (356)
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. (2013) (348)
Cardiac Hypertrophy, Aortic Compliance, Peripheral Resistance, and Wave Reflection in End‐Stage Renal Disease: Comparative Effects of ACE Inhibition and Calcium Channel Blockade (1994) (330)
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. (2004) (329)
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
Vascular calcification in chronic kidney disease. (2004) (323)
Arterial stiffness and pulse pressure in CKD and ESRD. (2012) (321)
Arterial stiffness and kidney function. (2004) (317)
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. (2006) (312)
Pathophysiology of anaemia: focus on the heart and blood vessels. (2000) (304)
Comparative effects of aging in men and women on the properties of the arterial tree. (2001) (300)
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. (2008) (272)
Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia (2005) (261)
Increased systolic pressure in chronic uremia. Role of arterial wave reflections. (1992) (259)
Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects (1997) (258)
Influence of sex on arterial hemodynamics and blood pressure. Role of body height. (1995) (250)
Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. (2001) (243)
Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension (2000) (242)
Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. (1993) (240)
Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. (1987) (239)
Influence of body height on pulsatile arterial hemodynamic data. (1998) (235)
Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. (2003) (235)
Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. (1988) (233)
Influence of arterial pulse and reflected waves on blood pressure and cardiac function. (1999) (232)
Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. (1989) (227)
Arterial structure and function in end-stage renal disease. (2002) (224)
The systemic nature of CKD (2017) (218)
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (212)
Left ventricular alterations and end-stage renal disease. (2002) (210)
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects (2004) (204)
Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. (1998) (201)
Cardiac disease in chronic uremia: pathogenesis. (1997) (200)
Remodeling of the radial artery in response to a chronic increase in shear stress. (1996) (199)
Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. (2001) (194)
Clinical Utility of Aortic Pulses and Pressures Calculated From Applanated Radial-Artery Pulses (2003) (193)
Arterial functions: how to interpret the complex physiology. (2010) (190)
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. (2005) (183)
Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. (1993) (182)
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. (2010) (178)
An evaluation of large arteries compliance in man. (1979) (168)
Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. (1989) (164)
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. (2007) (161)
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. (2015) (161)
Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. (1997) (161)
In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease (2007) (159)
Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. (2015) (155)
Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. (1999) (151)
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. (2001) (149)
Monocyte subpopulations and cardiovascular risk in chronic kidney disease (2012) (149)
Arterial stiffness: pathophysiology and clinical impact. (2004) (145)
Hemodynamic study of 85 patients with borderline hypertension. (1973) (139)
Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. (2000) (139)
Arterial and venous compliance in sustained essential hypertension. (1987) (138)
Aortic distensibility in normotensive, untreated and treated hypertensive patients. (1995) (136)
Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. (2000) (135)
Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. (2012) (134)
The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. (1987) (133)
Forearm reactive hyperemia and mortality in end-stage renal disease. (2004) (133)
Prognostic application of arterial stiffness: task forces. (2002) (133)
Increased stiffness of radial artery wall material in end-stage renal disease. (1997) (131)
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. (2015) (131)
Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal (2018) (129)
Recent advances on large arteries in hypertension. (1998) (127)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (2019) (125)
Salt and water retention and calcium blockade in uremia. (1990) (121)
Lipid management in patients with chronic kidney disease (2018) (119)
Pathophysiology of cardiovascular disease in hemodialysis patients. (2000) (118)
Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. (1987) (116)
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study. (2016) (114)
Pulmonary hypertension in CKD. (2013) (113)
Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial (2014) (112)
Assessment and significance of arterial stiffness in patients with chronic kidney disease (2008) (110)
Pathophysiology of cardiovascular damage in the early renal population. (2001) (110)
Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease. (1999) (110)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. (2010) (108)
Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. (1999) (100)
Endothelin and cardiovascular remodelling in end-stage renal disease. (1998) (99)
Hyperphosphataemia--a silent killer of patients with renal failure? (1999) (97)
Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. (2003) (97)
Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. (2004) (94)
Venous and arterial behavior during normal pregnancy. (1998) (93)
A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. (2014) (91)
Prognostic significance of arterial stiffness measurements in end-stage renal disease patients (2002) (86)
Arterial stiffness and function in end-stage renal disease. (2004) (85)
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. (2014) (84)
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients (2017) (84)
Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders (2006) (83)
Different Aortic Reflection Wave Responses Following Long‐Term Angiotensin‐Converting Enzyme Inhibition And Beta‐Blocker In Essential Hypertension (2001) (82)
COSMOS: the dialysis scenario of CKD-MBD in Europe. (2013) (80)
Body height as a determinant of carotid pulse contour in humans (1992) (80)
Arterial Stiffness in the Heart Disease of CKD. (2019) (78)
Total Effective Compliance, Cardiac Output and Fluid Volumes in Essential Hypertension (1978) (77)
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (75)
Renal and systemic hemodynamics in sustained essential hypertension. (1984) (73)
Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? (2013) (73)
Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. (1999) (72)
Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition (1996) (72)
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles (2016) (71)
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) (2014) (69)
Isoproterenol Sensitivity and Total Body Clearance of Propranolol in Hypertensive Patients (1976) (68)
Clinical management of the uraemic syndrome in chronic kidney disease. (2016) (67)
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
Hypertension and the arterial system: clinical and therapeutic aspects. (1990) (65)
Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients. (1983) (65)
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. (2013) (65)
Repeat hemodynamic determinations in borderline hypertension. (1978) (64)
Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study) (2016) (63)
Cardiopulmonary blood volume in borderline hypertension. (1974) (63)
Carotid arterial haemodynamics after mild degrees of lower-body negative pressure in man. (1992) (63)
Local shear stress and brachial artery functions in end-stage renal disease. (2007) (61)
Arterial structure and function in end-stage renal disease (2008) (60)
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE (2015) (59)
Large artery structure and function in hypertension and end‐stage renal disease (1998) (58)
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? (2014) (57)
Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients. (1985) (57)
The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial. (2019) (57)
Cardiovascular function in hemodialysis patients. (1991) (56)
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda (2011) (56)
Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring Methods, Thresholds, and Patterns (2016) (55)
Bone-vascular cross-talk. (2012) (55)
Alterations of Arterial Function in End-Stage Renal Disease (2000) (55)
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
Aortic Aging in ESRD: Structural, Hemodynamic, and Mortality Implications. (2016) (55)
Rapid Dextran Infusion in Essential Hypertension (1979) (54)
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. (2012) (53)
Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. (2015) (53)
Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes. (1990) (51)
Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project. (2016) (51)
Left ventricular hypertrophy: why does it happen? (2003) (50)
Mechanisms of arterial calcifications and consequences for cardiovascular function (2013) (50)
Blood pressure in the 'low-pressure system' and cardiac performance in essential hypertension. (1985) (50)
Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease (2011) (50)
Flow-mediated vasodilation in end-stage renal disease. (2011) (50)
Carotid arterial hemodynamics in response to LBNP in normal subjects: methodological aspects. (1995) (49)
Structural and functional modifications of peripheral large arteries in hypertensive patients. (1987) (49)
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? (2015) (48)
Cardiovascular risk in end-stage renal disease: vascular aspects. (2000) (48)
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? (2011) (47)
Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. (1983) (47)
Vascular reactivity to norepinephrine and hemodynamic parameters in borderline hypertension. (1975) (46)
Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease (2018) (46)
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (2012) (46)
Mineral and bone disease pattern in elderly haemodialysis patients. (2010) (46)
Role of arterial wall properties in the pathogenesis of systolic hypertension. (2005) (46)
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints (2019) (43)
Hemodynamic Overload in End‐Stage Renal Disease Patients (1999) (42)
Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. (2002) (40)
Pulse pressure in sustained essential hypertension: a haemodynamic study. (1987) (39)
Glomerular hypertension in renovascular hypertensive patients. (1991) (39)
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. (2006) (39)
Pathophysiology of left ventricular hypertrophy in dialysis patients. (1994) (39)
Comparative Effects of Captopril and Isosorbide Dinitrate on the Arterial Wall of Hypertensive Human Brachial Arteries (1986) (38)
Common Carotid Artery Diameter and Risk of Cardiovascular Events and Mortality: Pooled Analyses of Four Cohort Studies (2018) (37)
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. (2001) (37)
Multiphasic effects of blood pressure on survival in hemodialysis patients. (2016) (37)
Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. (2016) (36)
Sodium, large arteries and diuretic compounds in hypertension (1992) (35)
Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function. (1999) (35)
Effect of converting enzyme inhibitors on hypertensive large arteries in humans. (1986) (35)
Haemodynamics in patients with phaeochromocytoma. (1980) (35)
The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel. (1998) (35)
Arterial compliance in uraemia. (1989) (34)
Baroreflex sensitivity and cardiopulmonary blood volume in normotensive and hypertensive patients. (1977) (33)
Ankle-brachial index and bone turnover in patients on dialysis. (2015) (33)
Arterial mechanics predict cardiovascular risk in hypertension. (1997) (33)
Essential Hypertension: An Approach to Clinical Data by the Use of Models (1979) (33)
Bone-vascular axis in chronic kidney disease: a reality? (2009) (33)
An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension. (1986) (32)
Effect of hemodialysis on cardiovascular rhythms in end-stage renal failure. (1995) (32)
Increased arterial stiffness in end-stage renal failure: why is it of interest to the clinical nephrologist? (1994) (32)
Left Ventricular Dysfunction in End-Stage Renal Disease: Echocardiographic Insights (1992) (31)
Arterial calcification: cardiovascular function and clinical outcome. (2011) (31)
Venous and arterial behavior during normal pregnancy. (1998) (31)
Systemic compliance, renal hemodynamics, and sodium excretion in hypertension. (1984) (31)
Control of cardiac output in essential hypertension. (1976) (30)
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
Arterial compliance in hypertension. (1989) (29)
Systolic Hypertension in Patients with Arteriosclerosis Obliterans of the Lower Limbs (1987) (29)
Influence of gender on the level of pulse pressure: the role of large conduit arteries. (1997) (29)
Arterial sti ff ening and vascular calcifications in end-stage renal disease (2000) (29)
Large artery function and alterations in hypertension (1995) (28)
Controversy on optimal blood pressure on haemodialysis: lower is not always better. (2001) (28)
Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension. (1994) (28)
Volume-dependent parameters in essential hypertension. (1977) (27)
Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients. (1989) (27)
Cardiovascular and renal medicine, an expanding territory (2011) (27)
Effect of head-down tilt on cardiovascular control in healthy subjects: a spectral analytic approach. (1995) (27)
Tilt test in essential hypertension. Differential responses in heart rate and vascular resistance. (1987) (27)
Hemodynamics of the carotid artery after vasodilation in essential hypertension. (1988) (27)
Renal filtration fraction, effective vascular compliance, and partition of fluid volumes in sustained essential hypertension. (1981) (27)
Cardiovascular disease in renal failure. (2004) (27)
Relationships between cardiac output, heart rate and blood volume in essential hypertension. (1978) (26)
Vascular Calcifications, Arterial Aging and Arterial Remodeling in ESRD (2013) (26)
Arterial alterations in hypertension with a disproportionate increase in systolic over diastolic blood pressure (1996) (26)
Modeling the implications of changes in vascular calcification in patients on hemodialysis. (2005) (26)
Total effective compliance of the vascular bed in essential hypertension. (1978) (26)
Altered blood volume regulation in sustained essential hypertension: a hemodynamic study. (1975) (26)
Systemic Arterial Compliance in Patients with Arteriosclerosis Obliteransof the Lower Limbs: Observations on the Effect of Intravenous Propranolol (1982) (26)
Contributive factors to cardiovascular hypertrophy in renal failure. (1989) (24)
High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (24)
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (23)
Forearm haemodynamics in obese normotensive and hypertensive subjects. (1988) (23)
Soft Bone – Hard Arteries: A Link (2011) (23)
Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research. (2015) (22)
The complexity of the cardio–renal link: taxonomy, syndromes, and diseases (2011) (21)
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease (2018) (21)
Increased response of brachial artery diameter to norepinephrine in hypertensive patients. (1988) (21)
Meaning of the cardiac output-blood volume relationship in essential hypertension. (1982) (21)
Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery. (1989) (21)
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. (2016) (20)
Arterial Compliance and Blood Pressure (2012) (20)
Brachial artery diameter changes associated with cardiopulmonary baroreflex activation in humans. (1990) (19)
Calcium‐Entry Blockers and Arterial Compliance in Hypertension (1989) (18)
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial (2016) (18)
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (18)
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. (2019) (18)
The pressure-volume relationship in normotensive and permanent essential hypertensive patients. (1976) (17)
Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar‐Kyoto and spontaneously hypertensive rats (1995) (17)
Brachial Artery Cross‐Sectional Area and Distensibility Before and After Arteriolar Vasodilatation in Men with Sustained Essential Hypertension (1987) (17)
Central haemodynamics and plasma prostaglandin E2 in borderline and sustained essential hypertensive patients before and after indomethacin. (1981) (17)
Pressure-overload cardiomyopathy in end-stage renal disease (1999) (17)
Blood pressure control in chronic hemodialysis patients (1996) (17)
Thromboxane B2 in borderline and essential hypertensive patients. (1983) (17)
Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics. (1975) (17)
Elevation of brachial arterial blood velocity and volumic flow mediated by peripheral beta-adrenoreceptors in patients with borderline hypertension. (1985) (16)
Atherosclerosis versus arterial stiffness in advanced renal failure. (2007) (16)
[Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008]. (2010) (16)
Ultrafiltration intensification for achievement of dry weight and hypertension control is not always the therapeutic gold standard. (2011) (16)
Heterogeneity of left ventricular hypertrophy--does it have clinical implications? (1998) (16)
The ratio between ankle and brachial systolic pressure in patients with sustained uncomplicated essential hypertension. (1988) (16)
The meaning of dopamine beta-hydroxylase in essential hypertension. (1975) (16)
Vascular Disease and Atherosclerosis in Uremia (2000) (15)
Large arteries haemodynamics: conduit versus cushioning function. (1997) (15)
The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
Effect of cadralazine on brachial artery hemodynamics and forearm venous tone in essential hypertension (1986) (15)
Determination of total effective vascular compliance in patients with sepsis syndrome. (1998) (15)
Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. (1977) (14)
The use of echocardiography in observational clinical trials: the EURECA-m registry. (2013) (14)
Effects of antihypertensive agents on carotid pulse contour in humans. (1992) (14)
Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review (2017) (14)
Arterial Stiffness Gradient, Systemic Reflection Coefficient, and Pulsatile Pressure Wave Transmission in Essential Hypertension. (2019) (13)
Cardiomyopathy in End‐Stage Renal Failure (1989) (13)
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial (2016) (13)
Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness. (2015) (13)
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage. (2021) (13)
Hysteresis of the venous pressure-volume relationship in the forearm of borderline hypertensive subjects. (1992) (13)
Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation. (1989) (13)
Venous system in essential hypertension. (1985) (12)
INCREASED VASODILATOR RESPONSE DURING STIMULATION OF CARDIOPULMONARY BARORECEPTORS IN BORDERLINE HYPERTENSIVES (1989) (12)
Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients. (2018) (12)
Split intrarenal hemodynamics in renovascular hypertension. (1991) (12)
Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure (2004) (12)
Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems (2011) (11)
Cardiovascular disease in end-stage renal failure (2000) (11)
Optimizing hypertension management in renal transplantation: a call to action. (2017) (11)
Overhydratation and renin in hypertensive patients with terminal renal failure: a hemodynamic study. (1975) (11)
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension (2021) (11)
Twenty-four hours of bed rest with head-down tilt: venous and arteriolar changes of limbs. (1991) (11)
Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics (2008) (11)
Clinical imaging of vascular disease in chronic kidney disease (2016) (11)
Wave reflections. Clinical and therapeutic aspects (1993) (10)
Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes. (2019) (10)
K026: Impact of aortic stiffness on survival in end-stage renal failure (1998) (10)
Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. (2017) (10)
Optimizing hypertension management in renal transplantation: a call to action. (2017) (10)
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study (2013) (10)
Estimating central blood pressure in the extreme vascular phenotype of advanced kidney disease. (2016) (10)
Cardiopulmonary blood volume and plasma renin activity in normal and hypertensive humans. (1985) (10)
Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease (2018) (9)
Arterial function in renal failure. (1998) (9)
Arteriosclerosis and Antihypertensive Response to Calcium Antagonists in End‐Stage Renal Failure (1991) (9)
Abstract 4871: Circulating Endothelial Microparticles: A Novel Biomarker for Prediction of Subsequent Death and Cardiovascular Events in End-stage Renal Disease (2009) (9)
Influence of sex and body weight on forearm hemodynamics in patients with sustained essential hypertension. (1991) (9)
Effect of alpha‐methyldopa on cardiac output in hypertension (1979) (9)
Intrinsic modifications of the brachial and radial arteries in hypertensive humans. (1994) (9)
Comparison of forearm plethysmographic methods with brachial artery pulsed Doppler flowmetry in man. (1988) (9)
Arterial remodeling and cardiovascular function in end-stage renal disease. (1997) (9)
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study (2017) (9)
Plasma prostaglandins PGE2 and PGF2 alpha, total effective vascular compliance and renal plasma flow in essential hypertension. (1982) (8)
Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans. (1987) (8)
Cinacalcet, FGF23 and Cardiovascular Disease in Hemodialysis: The EVOLVE Trial (2015) (8)
Total, peripheral and intrathoracic effective compliances of the vascular bed in normotensive and hypertensive patients. (1982) (8)
Cardiovascular disease in end-stage renal failure: role of calcium-phosphate disturbances and hyperparathyroidism. (2002) (8)
Prognostic values of left ventricular mass index in chronic kidney disease patients. (2019) (8)
Central Artery Pulse Pressure in End-Stage Renal Disease: The Roles of Aortic Diameter, Aortic Stiffness and Wave Reflection (2011) (8)
Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition. (1992) (8)
Protocol of the SPARTE Study: A Strategy for Preventing Cardiovascular and Renal Events based on ARTErial Stiffness (2020) (8)
Free erythrocyte protoporphyrin level and nerve conduction velocity in end-stage renal disease. (1975) (7)
The common carotid circulation in patients with essential hypertension. (1988) (7)
Age- and Sex-Related Changes in the Ratio Between Ankle and Brachial Systolic Pressure in Normal Subjects (1988) (7)
Physical properties of the aorta and cardiac hypertrophy in essential hypertension. (1990) (7)
[Incidence of arterial hypertension in French population after 60 years]. (2012) (7)
Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study (2017) (7)
[Arteriosclerosis and arterial calcifications in chronic kidney insufficiency]. (2005) (7)
Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study (2020) (7)
Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients (2018) (6)
Difference in response of vascular resistance to orthostasis in patients with borderline and sustained essential hypertension. (1988) (6)
[Cardiac anomalies in chronic renal failure]. (2000) (6)
Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition (1992) (6)
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? (2011) (6)
ANTIHYPERTENSIVE EFFICACY OF INDAPAMIDE SR VS CANDESARTAN AND AMLODIPINE IN HYPERTENSIVE PATIENTS: THE X-CELLENT MAIN STUDY (2004) (6)
Autonomic nervous system and large conduit arteries (1993) (6)
Enhanced brachial artery compliance following perindopril in essential hypertension. (1988) (6)
Cardiac output, oxygen consumption and renal blood flow in essential hypertension. (1984) (6)
[Arterial hypertension, chronic renal insufficiency and dialysis]. (2007) (5)
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis (2021) (5)
Arterial Pulse Wave and Calcium‐Channel Blockers in Hypertension (1994) (5)
Arterial Calcinosis, Chronic Renal Failure and Calcium Antagonism (2012) (5)
Cardiopulmonary baroreflex control of brachial artery diameter in sustained essential hypertension. (1989) (5)
Aortic pulse wave velocity as a marker of atherosclerosis in hypertension (2001) (5)
From Profusion to Confusion: The Saga of Managing Hypertension in Chronic Kidney Disease! (2015) (5)
Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure. (1990) (5)
Renal and systemic hemodynamics in borderline hypertension. (1988) (5)
A case-control study indicates that coagulation imbalance is associated with arteriosclerosis and markers of endothelial dysfunction in kidney failure. (2020) (5)
[Pressure-independent improvement of aortic distensibility in hypertensive hemodialysed patients]. (1994) (4)
Antihypertensive therapy and wave reflections. (1996) (4)
Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
Central hemodynamics and cardiac output control in essential hypertensive patients. (1977) (4)
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study. (2020) (4)
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
Vascular disease and atherosclerosis in uremia. (2005) (4)
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study) (2015) (4)
Erratum to: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. (2019) (4)
[Comparison of central pulse pressure estimated from pulse wave propagation velocity and carotid pulse pressure measured by applantation tonometry]. (2002) (4)
Renal haemodynamics, sodium balance and the capacitance system in essential hypertension. (1988) (4)
[Hypertension and pulse pressure]. (2000) (4)
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study (2019) (4)
Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views. (2019) (4)
Cardiac Hypertrophy and Aortic Distensibility in Essential Hypertension (1987) (4)
Indirect, Noninvasive Evaluation of Pressure Wave Transmission in Essential Hypertension (1989) (3)
Further study on the carotid baroreflex system in the cardiovascular deconditioning induced by head-down tilt. (1998) (3)
Association of height and risk of myocardial infarction in women. (1995) (3)
Cardiac Hypertrophy and Arterial Compliance Following Drug Treatment in Hypertension (1991) (3)
Non-invasive assessment of vascular calcification and arterial stiffness (2010) (3)
172 Sexual Activity in Hypertensive Men Treated With Valsartan or Carvedilol (2001) (3)
Arterial stiffness in hypertensive subjects with or without end-stage renal disease. (1997) (3)
Promoting scientific collaboration and education in cardiovascular–renal medicine (2009) (3)
APPLANATION TONOMETRY: SYSTOLIC BLOOD PRESSURE AND PULSE PRESSURE (PP) UNDER TREATMENT WITH INDAPAMIDE SR VERSUS CANDESARTAN AND AMLODIPINE (2004) (3)
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study]. (2002) (3)
[Arterial stiffness, wave reflections and myocardial protection: the REASON project]. (2003) (3)
AORTIC PULSE WAVE VELOCITY INDEX AND MORTALITY IN END-STAGE RENAL DISEASE: P3.170 (2000) (3)
Awareness of Vascular Calcification Alters Mineral Metabolism Management: VASCULAR CALCIFICATION IN DIALYSIS PATIENTS (2010) (3)
Differences in the mechanisms of borderline and permanent hypertension. (1977) (3)
Renal replacement therapy for heart failure patients: in whom, when and which therapy to use? (2009) (3)
[A new approach of the hemodynamics of human essential hypertension. Study of the control of cardiac output]. (1976) (3)
Venous compliance in essential hypertension (1987) (3)
Renal blood flow in man with essential hypertension. (1986) (3)
[Hyperreactivity of the humeral artery to noradrenaline in essential hypertension patients]. (1987) (2)
Effects of twenty-four hours of bed rest with head-down tilt on cardiopulmonary baroreflex control: preliminary study. (1989) (2)
[Evaluation of the individual absolute cardiovascular risk. A mathematical equation and/or arterial measurement?]. (1999) (2)
K025 Aortic pulse wave velocity (PWV): Marker of cardiovascular risk in hypertensive patients (1998) (2)
INDAPAMIDE SR ANTIHYPERTENSIVE EFFICACY VS CANDESARTAN AND AMLODIPINE IN ISOLATED SYSTOLIC HYPERTENSIVE PATIENTS: THE X-CELLENT ISH SUBSET (2004) (2)
Sex dependence of body fat distribution and fluid volumes in hypertension. (1988) (2)
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study (2020) (2)
[Changes in mineral and bone disorder management in a French cohort of hemodialysis patients between 2008 and 2012: The National Bone and Mineral Metabolism observatory (Photo-Graphe 2 and 3)]. (2016) (2)
Vascular Compliance in Hypertension: Therapeutic Implications (1987) (2)
Benefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results (2003) (2)
Author Correction: Lipid management in patients with chronic kidney disease (2018) (2)
The spectrum of pressor-response to norepinephrine in normotensive and hypertensive patients. (1976) (2)
Ambulatory blood pressure changes with lung ultrasound-guided dry-weight reduction in hypertensive hemodialysis patients: 12-month results of a randomized controlled trial (2021) (2)
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study. (2019) (2)
The stroke volume in juvenile borderline hypertension. (1975) (2)
Intrinsic alterations of the arterial wall in hypertension and effect of antihypertensive therapy (1987) (2)
Total effective vascular compliance and renal filtration fraction in normotensive subjects and essential hypertensive patients. (1984) (2)
[Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe]. (2017) (2)
[Venous tone of the limbs. Methods and comparison of 2 areas]. (1989) (2)
Epidemiology and outcome - 1 (2009) (2)
CIRCULATING ENDOTHELIAL MICROPARTICLES PREDICT CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE: 3A.06 (2010) (1)
What does STOP-2 tell us about management of hypertension? (2000) (1)
Cardiopulmonary blood volume and plasma renin activity in man: preliminary report. (1985) (1)
FP357 THE CLINICAL EVALUATION OF LOW DOSE HEPARIN IN HEMODIALYSIS: A PROSPECTIVE STUDY USING THE HEPARIN-COATED AN69 ST MEMBRANE (2007) (1)
Arterial structure and function and blockade of the renin-angiotensin system in hypertension (2001) (1)
[Measurement of the carotid intima-media thickness. An innovative technique for assessing cardiovascular risk]. (2001) (1)
The possible impact of arterial compliance on cardiac hypertrophy in arterial hypertension. (1989) (1)
APPLANATION TONOMETRY: ARTERY MECHANICAL PROPERTIES OF INDAPAMIDE SR VS CANOESARTAN AND AMLODIPINE (2004) (1)
Borderline hypertension: correlation between the cardiac output and the vascular reactivity to norepinephrine. (1974) (1)
β‐Blockade and Brachial Artery Hemodynamics in Hypertension (1990) (1)
P-231: Slow release nifedipine (GITS) and lack of catecholamine reactivity in essential hypertension (2001) (1)
Large arteries and calcium in hypertension (1993) (1)
Disturbed Calcium-Phosphorus Metabolism/Arterial Calcifications: Consequences on Cardiovascular Function and Clinical Outcome (2010) (1)
THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2019) (1)
P-408: Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in isolated systolic hypertensive patients (2004) (1)
26 Pressure‐independent improvement in aortic distensibility in hypertensives undergoing haemodialysis (1994) (1)
Reversion ofCardiac Hypertrophy andReduced Arterial Compliance After Converting EnzymeInhibition inEssential Hypertension (1988) (1)
Erratum: Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: A study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA (Nephrology Dialysis Transplantation (2018) (gfy147) DOI: 10.1093/NDT/gfy147) (2018) (1)
SuO002OPTIMAL BLOOD PRESSURE AND SURVIVAL IN HAEMODIALYSED PATIENTS. A PROSPECTIVE NATIONWIDE COHORT (2015) (0)
POOR ADHERENCE TO BLOOD PRESSURE MEASUREMENT RECOMMENDATIONS IN EUROPEAN DIALYSIS CENTERS (2018) (0)
Advanced Oxidation Protein Products , and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease (2002) (0)
Diameter, Velocity and Blood Flow of the Common Carotid Artery Before and After Vasodilation in Essential Hypertension (1986) (0)
The meaning of dopamine p-hydroxylase in essential hypertension (2012) (0)
[Cardiovascular repercussions of chronic hemodialysis]. (1990) (0)
Lessons learned from EVOLVE for the planning of future global randomized trials in chronic kidney disease (2016) (0)
Low-pressure system in essential hypertension. (1986) (0)
EFFICACY OF NATRILIX SR IN THE LOWERING OF SYSTOLIC BLOOD PRESSURE: S6 (2004) (0)
FO041THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
Opponent's comments. (2015) (0)
Sodium, large arteries, and diuretic compounds in hypertension. (1994) (0)
Survival with low- and high-flux dialysis (2020) (0)
Influence of the autonomic nervous system on brachial artery diameter and compliance in normotensive and hypertensive patients. (1989) (0)
Systemic hemodynamics in sustained essential and reno-vascular hypertension (1989) (0)
E16: Plasma homocysteine (HCY), endothelin (ET) and left ventricular hypertrophy in patients with end-stage renal disease (ESRD) (1997) (0)
Arterial Interactions with Mineral and Bone Disorders (2015) (0)
Clinical consequences of arterial calcifications and soft-tissue calcifications in chronic kidney disease (2010) (0)
P2640The effect of dry-weight reduction guided by lung ultrasound on ambulatory aortic blood pressure and arterial stiffness parameters in hemodialysis patients (2019) (0)
Large arteries and calcium in hypertension. Pathophysiological and therapeutic aspects (1993) (0)
[PP.07.30] AMBULATORY PULSE WAVE VELOCITY AND AUGMENTATION INDEX PREDICT CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENT (2017) (0)
Renal anaemia - CKD 5D (2012) (0)
Heart and bone in CKD - A (2013) (0)
Evolving concepts of pathogenesis of cardiovascular disease in chronic uremia: Role of hyperparathyroidism, calcium-phosphate metabolism, and their therapy (2002) (0)
Cardiovascular complications in end-stage renal disease patients (2015) (0)
The reason project: blood pressure evaluation (2001) (0)
DIALYSIS. EXTRACORPOREAL DIALYSIS: TECHNIQUES AND ADEQUACY FP473 THE USE OF HIGH-FLUXMEMBRANES IS NOTASSOCIATED WITH IMPROVED SURVIVALOF PATIENTS ON HEMODIALYSIS (2015) (0)
Venous system, extracellular fluid volume and the kidney in essential hypertension (1987) (0)
Acute volume expansion and pumping function of the heart in sustained essential hypertension (1989) (0)
The Age–Stiffness Relationships of Elastic and Muscular Arteries in a Control Population and in End-Stage Renal Disease Patients (2023) (0)
FP685THE PROGNOSTIC SIGNIFICANCE OF THE BLOOD PRESSURE-PULSE WAVE VELOCITY ASSOCIATION FOR CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEMODIALYSIS PATIENTS (2019) (0)
P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE (2020) (0)
Evaluation de la compliance artérielle chez l'insufficient rénal (1991) (0)
THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS (2019) (0)
[Index of arterial and venous compliance and echocardiographic parameters in essential permanent arterial hypertension]. (1987) (0)
15th International Conference on Dialysis Advances in Chronic Kidney Disease 2013 (2013) (0)
A955 Differential Influence of Pregnancy on Limbs Venous Tone in Humans (1990) (0)
PowerPoint Slides for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
[Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients]. (1988) (0)
[Current physiopathological concerns in arterial hypertension]. (1990) (0)
[Abnormalities of intrarenal hemodynamics in essential and renovascular hypertension in man]. (1989) (0)
Under embargo until June 2 , 2014 , 09 : 30 local time ! LATE BREAKING CLINICAL TRIALS Hyperparathyroidism : Medical or Surgical Treatment ? (2014) (0)
Supplementary Material for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. (1991) (0)
[Influence of the autonomic nervous system on the diameter and compliance of the brachial artery in normotensive subjects and hypertensive patients]. (1989) (0)
Non‐invasive ultrasonic study of maximal aortic blood acceleration in patients with borderline and sustained essential hypertension (1988) (0)
Blockade in Uremia (2005) (0)
[Comparison of renal hemodynamics in 2 types of arterial hypertension, essential and renovascular, in man. Physiopathological implications]. (1988) (0)
[Plasma prostaglandins and the renin-aldosterone system in patients with labile or permanent essential hypertension]. (1978) (0)
FP473THE USE OF HIGH-FLUX MEMBRANES IS NOT ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS ON HEMODIALYSIS (2015) (0)
Autonomic Nervous System and Brachial Artery Diameter in Normotensive and Hypertensive Patients (1990) (0)
Calf venous modifications during pregnancy: preliminary report. (1991) (0)
[Labile arterial hypertension and prostaglandins]. (1977) (0)
Beta-blockade and brachial artery hemodynamics in hypertension. (1990) (0)
dialysate calcium is an independent risk factor for Low parathyroid hormone status induced by high cardiovascular death in hemodialysis patients (2016) (0)
FC 079HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY (2021) (0)
E32 Stiffness of radial artery wall material in essential hypertension and end-stage renal disease (1997) (0)
Cardiovascular complications in CKD 5D (2) (2011) (0)
Bone disease - 2 (2009) (0)
Large Artery Remodeling and Chronic Kidney Disease (2014) (0)
383 ARTERIAL HEMODYNAMICS IN CALCIFIED ARTERIOPATHIES AND THEIR INFLUENCE ON MICROCIRCULATION (2012) (0)
Prostaglandins and plasma renin activity in hypertensive patients. (1980) (0)
Increased bone aluminum deposition after parathyroidectomy in hemodialyzed patients (1985) (0)
Subject Index, Vol. 6 (Suppl. 2), 1986 (1986) (0)
FP592TWO-YEAR EVOLUTION OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS BACK TO DIALYSIS AFTER KIDNEY TRANSPLANT FAILURE. (2018) (0)
VASODILATATION INDEPENDENT FROM ENDOTHELIUM IS ALTERED IN RELATION WITH ARTERIAL STIFFNESS: P 467 (2004) (0)
SP543AMBULATORY ARTERIAL STIFNESS PARAMETERS PREDICT CARDIOVASCULAR AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2017) (0)
NDT Perspectives A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Non-dialysis-dependent Chronic Kidney Disease: an endorsement with some caveats for real-life applica (2014) (0)
SaO048THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
SP608LEFT VENTRICULAR MASS IS A POWERFUL PROGNOSTIC FACTORFOR ALL-CAUSE MORTALITY IN END STAGE KIDNEY DISEASE PATIENTS: A COMBINED ANALYSIS OF TWO EUROPEAN COHORTS (2016) (0)
[Non-invasive study of the role of carotid distension in the baroreflex response to the arteriolar vasodilator cadralazine in essential hypertension]. (1986) (0)
P279 NUTRITIONAL AND METABOLIC PATTERN IN 9000 MAINTENANCE HEMODIALYSIS PATIENTS FROM THE FRENCH NATIONAL CALCIUM AND PHOSPHATE OBSERVATORY: ANALYSIS FROM JUNE 2008 DATA (2009) (0)
FP626LOW PARATHYROID HORMONE STATUS INDUCED BY HIGH DIALYSATE CALCIUM IS AN INDEPENDENT RISK FACTOR OF CARDIOVASCULAR DEATH IN HAEMODIALYSIS PATIENTS (2015) (0)
SP333MANAGEMENT OF BONE AND MINERAL METABOLISM DISORDERS BEFORE THE DIALYSIS STAGE REMAINS STILL PERFECTIBLE DATA FROM THE FRENCH PHOSPHORUS AND CALCIUM SURVEY « PHOTO-GRAPHE» (2017) (0)
FP402RELATIVE RISK OF MORTALITY IN HEMODIALYSIS PATIENTS PRESCRIBED CALCIUM-FREE AND CALCIUM-CONTAINING PHOSPHATE BINDING AGENTS (2015) (0)
Central Pulse Pressure in end-stage renal disease: the role of aortic diameter, aortic stiffness and wave reflection (2008) (0)
FP633PULSE WAVE VELOCITY AND PROGNOSIS IN CHRONIC KIDNEY FAILURE (2018) (0)
MO102LUNG ULTRASOUND-GUIDED DRY-WEIGHT REDUCTION DECREASES AMBULATORY BLOOD PRESSURE LEVELS IN HYPERTENSIVE HEMODIALYSIS PATIENTS: LONG-TERM ANALYSIS OF A LUST SUB-STUDY* (2021) (0)
MP344THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY (2016) (0)
[Methods for studying vasodilator agents in arterial hypertension]. (1990) (0)
HIGH BLOOD PRESSURE INCIDENCE AND PREDICTIVE FACTORS ACCORDING TO AGE IN THE IPC COHORT: PP.30.28 (2011) (0)
SAT-019 ACEi/ARBs, β-blockers or Both in incident End-Stage Renal Disease patients without Cardiovascular Disease: A Propensity-Matched longitudinal study in a Nationwide cohort (2019) (0)
Effects of Parathyroidectomy on Plasma Different Parathyroid Hormone Fragments Levels in Chronic Kidney Disease Patients (2017) (0)
Anaemia in CKD 5D (2011) (0)
[Evaluation of arterial compliance in renal insufficiency]. (1991) (0)
[Cardiac hypertrophy and arterial compliance after antihypertensive treatment]. (1991) (0)
Selected Abstracts from the 31th International Vicenza Course on Critical Care Nephrology. Vicenza, June 11-14, 2013 (2013) (0)
Erratum. (2020) (0)
Baroreflex sensitivity andcardiopulmonary blood volume innormotensive andhypertensive patients (1977) (0)
[New approach to the hemodynamics of human essential hypertension. Study of mean values]. (1976) (0)
Vascular reactivity to angiotensin in borderline hypertension. (1974) (0)
[Hemodynamic effect of propranolol in permanent essential arterial hypertension]. (1974) (0)
SP55824-MONTH SAFETY OUTCOMES OF BIOSIMILAR EPOETIN ALFA IN THE EUROPEAN MONITOR-CKD5 PHARMACOEPIDEMIOLOGICAL STUDY OF ANAEMIA IN HAEMODIALYSIS (2016) (0)
P1584The prognostic significance of the blood pressure-pulse wave velocity association for cardiovascular outcomes and mortality in hemodialysis patients (2019) (0)
PP.30.28 HIGH BLOOD PRESSURE INCIDENCE AND PREDICTIVE FACTORS ACCORDING TO AGE IN THE IPC COHORT (2012) (0)
Systemic hemodynamics in patients with pheochromocytoma (1989) (0)
[Value of arterial rigidity measurements in cardiovascular pathology]. (1999) (0)
[Increased vasodilation response to the stimulation of low pressure mechanoreceptors in borderline hypertension]. (1989) (0)
In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis (2012) (0)
HEMODYNAMIC DETERMINANTS OF CORONARY AND STROKE MORTALITY IN HEMODIALYSED PATIENTS: 2B.6 (2004) (0)
THE PROGNOSTIC SIGNIFICANCE OF THE BLOOD PRESSURE-PULSE WAVE VELOCITY ASSOCIATION FOR CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEMODIALYSIS PATIENTS (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gérard Michel London?

Gérard Michel London is affiliated with the following schools:

Gérard Michel London's Academic­Influence.com Rankings

Why Is Gérard Michel London Influential?

Gérard Michel London's Published Works

Published Works

What Schools Are Affiliated With Gérard Michel London?

Gérard Michel London's AcademicInfluence.com Rankings